Login / Signup

Post-transfusion hyperhemolysis syndrome in a patient with beta thalassemia major.

Ganesh KasinathanJameela Sathar
Published in: Clinical case reports (2021)
Hyperhemolysis syndrome (HS) is characterized by the occurrence of severe anemia with post-transfusion hemoglobin and hematocrit levels being markedly lower than those present prior to transfusion. A high index of suspicion of HS in a multi-transfused thalassemia patient allows prompt institution of therapy resulting in improved survival outcome.
Keyphrases
  • sickle cell disease
  • case report
  • cardiac surgery
  • chronic kidney disease
  • risk assessment
  • red blood cell
  • early onset
  • stem cells
  • mesenchymal stem cells